1h Free Analyst Time
The female contraceptive market is poised to grow by $5142.22 mn during 2023-2027, accelerating at a CAGR of 5.32% during the forecast period. The report on the female contraceptive market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption of innovative marketing strategies, evolving consumer perspectives, and the availability of different methods of contraception.
The female contraceptive market is segmented as below:
By Distribution Channel
- Offline
- Online
By Product
- Female contraceptive devices
- Female contraceptive drugs
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the female contraceptive market covers the following areas:
- Female contraceptive market sizing
- Female contraceptive market forecast
- Female contraceptive market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global female contraceptive market: AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson and Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck and Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing popularity of female condoms.`
According to the report, one of the major drivers for this market is the increasing adoption of innovative marketing strategies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Afaxys Pharma LLC
- Agile Therapeutics Inc.
- Amgen Inc.
- Ansell Ltd.
- Bayer AG
- CooperSurgical Inc.
- Cupid Ltd.
- Exeltis USA Inc.
- Johnson and Johnson
- Mayer Laboratories Inc.
- Medisafe Distribution Inc.
- Merck and Co. Inc.
- Mylan NV
- Pfizer Inc.
- Piramal Enterprises Ltd.
- Reckitt Benckiser Group PLC
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Veru Inc.